The DOI matches its Crossref record.
Ischemia Modified Albumin Is a Sensitive Marker of Myocardial Ischemia After Percutaneous Coronary Intervention
Open accessAbstract
Background— Ischemia modified albumin (IMA; Ischemia Technologies, Inc) blood levels rise in patients who develop ischemia during percutaneous coronary intervention (PCI). It is not known whether IMA elevations correlate with increases in other markers of oxidative stress, ie, 8-iso prostaglandin F2-A (iP). Methods and Results— We compared IMA versus iP plasma levels in 19 patients (mean age 62.8±11.9 years) undergoing PCI and 11 patients (mean age 64±13.6 years) undergoing diagnostic angiography (controls). In the PCI patients, blood samples for IMA and iP were taken from the guide catheter before PCI and after balloon inflations, and from the femoral sheath 30 minutes after PCI. IMA was measured by the albumin cobalt binding (ACB) test and plasma iP by enzyme immunoassay. During PCI, all 19 patients had chest pain and 18 had transient ischemic ST segment changes. IMA was elevated from baseline in 18 of the 19 patients after PCI. Median IMA levels were higher after PCI (101.4 U/mL, 95%CI 82 to 116) compared with baseline (72.8 U/mL, CI 55 to 93; P <0.0001). Levels remained elevated at 30 minutes (87.9 U/mL, CI 78 to 99; P <0.0001) and returned to baseline at 12 hours (70.3 U/mL, CI 65 to 87; P =0.65). iP levels were raised after PCI in 9 of the 19 patients. However, median iP levels were not significantly different immediately ( P =0.6) or 30 minutes after PCI ( P =0.1). In the control group, IMA and iP levels remained unchanged before and after angiography ( P =0.2 and 0.16, respectively). Conclusions— IMA is a more consistent marker of ischemia than iP in patients who develop chest pain and ST segment changes during PCI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antioxidants and human diseases
Rajendran, P., Nandakumar, N., Rengarajan, T., Palaniswami, R., Gnanadhas, E. N., Lakshminarasaiah, U., Gopas, J., & Nishigaki, I. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.06.004 · Cited by 523
Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications
Garcia-Martinez, R., Caraceni, P., Bernardi, M., Gines, P., Arroyo, V., & Jalan, R. (2013) · Hepatology · doi:10.1002/hep.26338 · Cited by 471
Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome
Apple, F. S. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046292 · Cited by 426
Low serum albumin: A neglected predictor in patients with cardiovascular disease
Manolis, A. A., Manolis, T. A., Melita, H., Mikhailidis, D. P., & Manolis, A. S. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.05.004 · Cited by 353
Peri-procedural myocardial injury: 2005 update
Herrmann, J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi455 · Cited by 325
Metadata
- Authors
- Sinha, M. K., Gaze, D. C., Tippins, J. R., Collinson, P. O., & Kaski, J. C.
- Venue
- Circulation
- Published
- 2003-05-20
- Volume
- 107
- Issue
- 19
- Pages
- 2403-2405
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2161070498
- Cited by
- 218
- References
- 0
- FWCI
- 12.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ischemia Modified Albumin Is a Sensitive Marker of Myocardial Ischemia After Percutaneous Coronary Intervention. https://app.cochat.ai/papers/10.1161/01.cir.0000072764.18315.6b
- The paper
- Sinha, M. K., Gaze, D. C., Tippins, J. R., Collinson, P. O., & Kaski, J. C. (2003). Ischemia Modified Albumin Is a Sensitive Marker of Myocardial Ischemia After Percutaneous Coronary Intervention. Circulation. https://doi.org/10.1161/01.cir.0000072764.18315.6b
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.